Jan 01, 2026
As part
of the implementation of the instructions of the President of the Republic of
Kazakhstan to increase the share of domestic production in the pharmaceutical
industry to 50%, a major strategic investment project will be implemented in
Kazakhstan. The corresponding resolution has been signed by Prime-minister
Olzhas Bektenov.
The
document approved the draft Investment Agreement between the Ministry of healthcare
of the Republic of Kazakhstan and Khan Tengri Biopharma LLP for the
construction of a modern manufacturing complex in the Alatau Special Economic
Zone.
The
total volume of investments will exceed 103 billion tenge, and the project will
create more than 180 new permanent jobs.
The
implementation of this project is of strategic importance for the development
of Kazakhstan’s pharmaceutical industry and is aimed at expanding local
production, forming a sustainable manufacturing base, and as well as phased
import substitution of socially significant medicines. In addition, part of the
output goods are
planned for export to the markets of the EAEU, CIS, as well as countries of the
Middle East.